Role of training dose in discrimination of nicotine and related compounds by rats
- PMID: 6440189
- DOI: 10.1007/BF00555223
Role of training dose in discrimination of nicotine and related compounds by rats
Abstract
Rats were trained to discriminate nicotine from saline in a two-bar operant conditioning procedure with food reinforcement. There was partial generalization to the nicotine analogues anabasine and cytisine in rats trained to discriminate either 0.2 or 0.4 mg/kg nicotine from saline. However, generalization was complete in rats trained to discriminate 0.1 mg/kg nicotine and, in a novel procedure, any one of three doses of nicotine (0.1, 0.2, or 0.4 mg/kg). There was no generalization to the muscarinic-cholinergic agonist oxotremorine (0.0025-0.04 mg/kg). Additional experiments were carried to further characterize the response of rats trained with nicotine (0.1 mg/kg). These animals failed to generalize to compounds from a range of pharmacological classes (i.e., apomorphine, cocaine, chlordiazepoxide, picrotoxin, and quipazine), but there was partial generalization to amphetamine. Mecamylamine (0.5 mg/kg) but not hexamethonium (5.0 mg/kg) blocked the discrimination of nicotine and the generalization to cytisine. Anabasine (1.0-4.0 mg/kg) did not block the response to nicotine. The results support the view that the nicotine cue is mediated mainly through central cholinergic mechanisms. The dose of nicotine used for training has a very significant influence on the characteristics of the cue and 0.1 mg/kg of nicotine may be more suitable than 0.4 mg/kg as a training dose in future work.
Similar articles
-
Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms.Neuropharmacology. 1983 Sep;22(9):1029-37. doi: 10.1016/0028-3908(83)90021-7. Neuropharmacology. 1983. PMID: 6138726
-
Clozapine attenuates the discriminative stimulus properties of (-)-nicotine.Brain Res. 1994 Apr 18;643(1-2):1-9. doi: 10.1016/0006-8993(94)90002-7. Brain Res. 1994. PMID: 8032906
-
Discriminative stimulus properties of the nicotinic agonist cytisine.Psychopharmacology (Berl). 1997 Feb;129(3):257-64. doi: 10.1007/s002130050188. Psychopharmacology (Berl). 1997. PMID: 9084064
-
Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor.Psychopharmacology (Berl). 1983;81(1):54-60. doi: 10.1007/BF00439274. Psychopharmacology (Berl). 1983. PMID: 6415731
-
Primary cholinergic and indirect dopaminergic mediation of behavioural effects of nicotine.Prog Brain Res. 1989;79:227-37. doi: 10.1016/s0079-6123(08)62482-6. Prog Brain Res. 1989. PMID: 2573911 Review. No abstract available.
Cited by
-
Pharmacological characterization of the physostigmine stimulus in rats.Psychopharmacology (Berl). 1988;95(4):553-5. doi: 10.1007/BF00172975. Psychopharmacology (Berl). 1988. PMID: 3145526
-
Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.Psychopharmacology (Berl). 1989;98(1):1-19. doi: 10.1007/BF00442000. Psychopharmacology (Berl). 1989. PMID: 2498952 No abstract available.
-
Acute nicotine reinforcement requires ability to discriminate the stimulus effects of nicotine.Exp Clin Psychopharmacol. 2022 Jun;30(3):253-268. doi: 10.1037/pha0000433. Epub 2020 Oct 29. Exp Clin Psychopharmacol. 2022. PMID: 33119384 Free PMC article. Review.
-
Effects of isolated tobacco alkaloids and tobacco products on deprivation-induced food intake and meal patterns in rats.Pharmacol Biochem Behav. 2018 Feb;165:45-55. doi: 10.1016/j.pbb.2017.11.004. Epub 2017 Nov 28. Pharmacol Biochem Behav. 2018. PMID: 29196096 Free PMC article.
-
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.Pharmacol Rev. 2020 Apr;72(2):527-557. doi: 10.1124/pr.119.018028. Pharmacol Rev. 2020. PMID: 32205338 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources